{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:30:50Z","timestamp":1761611450711},"reference-count":13,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Zhejiang Jingxin Pharmaceutical Co LTD"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.jpba.2018.06.001","type":"journal-article","created":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T16:45:05Z","timestamp":1527871505000},"page":"282-290","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Simultaneous quantification of EVT201, a novel partial positive allosteric GABAA receptor modulator, and its two metabolites in human plasma by UHPLC\/MS\/MS"],"prefix":"10.1016","volume":"159","author":[{"given":"Xianhua","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Congya","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuangpeng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaofeng","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunmiao","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuanzhen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suodi","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2018.06.001_bib0005","doi-asserted-by":"crossref","first-page":"487","DOI":"10.5664\/jcsm.27286","article-title":"Clinical guideline for the evaluation and management of chronic insomnia in adults","volume":"4","author":"Schutte-Rodin","year":"2008","journal-title":"J. Clin. Sleep Med."},{"key":"10.1016\/j.jpba.2018.06.001_bib0010","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1378\/chest.14-0970","article-title":"International classification of sleep disorders-third edition: highlights and modifications","volume":"146","author":"Sateia","year":"2014","journal-title":"Chest"},{"key":"10.1016\/j.jpba.2018.06.001_bib0015","article-title":"A placebo controlled, randomized, double-blind, 5 way cross-over study of 4 doses of EVT201 on subjective sleep quality and morning after performance in a traffic noise model of sleep disturbance","volume":"30","author":"Boyle","year":"2007","journal-title":"Sleep"},{"key":"10.1016\/j.jpba.2018.06.001_bib0020","article-title":"A placebo controlled, randomized, double-blind, 4 way cross-over study of 3 doses of EVT201 (2.5\u202fmg, 5\u202fmg and 10\u202fmg) on aspects of sleep and morning after performance using a traffic noise model of sleep disturbance","volume":"29","author":"Stanley","year":"2006","journal-title":"Sleep"},{"key":"10.1016\/j.jpba.2018.06.001_bib0025","article-title":"EVT201: a high affinity, partial positive allosteric modulator of GABAA receptors with preference for the \u03b11-subtype","volume":"31","author":"Kemp","year":"2008","journal-title":"Sleep"},{"key":"10.1016\/j.jpba.2018.06.001_bib0030","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.sleep.2008.10.005","article-title":"The partial positive allosteric GABAA receptor modulator EVT201 is efficacious and safe in the treatment of adult primary insomnia patients","volume":"10","author":"Walsh","year":"2009","journal-title":"Sleep Med."},{"key":"10.1016\/j.jpba.2018.06.001_bib0035","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.sleep.2009.07.012","article-title":"Treatment of elderly primary insomnia patients with EVT201 improves sleep initiation, sleep maintenance, and daytime sleepiness","volume":"11","author":"Walsh","year":"2010","journal-title":"Sleep Med."},{"key":"10.1016\/j.jpba.2018.06.001_bib0040","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1093\/jat\/bks059","article-title":"Sensitive UPLC-MS-MS assay for 21 benzodiazepine drugs and metabolites, zolpidem and zopiclone in serum or plasma","volume":"36","author":"Marin","year":"2012","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.jpba.2018.06.001_bib0045","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.forsciint.2016.12.026","article-title":"Development and validation of a fast ionic liquid-based dispersive liquid-liquid microextraction procedure combined with LC-MS\/MS analysis for the quantification of benzodiazepines andbenzodiazepine-like hypnotics in whole blood","volume":"274","author":"De Boeck","year":"2017","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.jpba.2018.06.001_bib0050","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.legalmed.2016.11.005","article-title":"Rapid and highly sensitive analysis of benzodiazepines and tandospirone in human plasma by automated on-line column-switching UFLC-MS\/MS","volume":"24","author":"Lee","year":"2017","journal-title":"Leg. Med."},{"key":"10.1016\/j.jpba.2018.06.001_bib0055","article-title":"Development of a UPLC-MS\/MS method for routine therapeutic drug monitoring of aripiprazole, amisulpride, olanzapine, paliperidone and ziprasidone with a discussion of their therapeutic reference ranges for Chinese patients","volume":"31","author":"Wang","year":"2017","journal-title":"Biom. Chromatogr."},{"key":"10.1016\/j.jpba.2018.06.001_bib0060","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00216-013-7513-x","article-title":"Detection and quantification of benzodiazepines and Z-drugs in human whole blood plasma, and serum samples as part of a comprehensive multi-analyte LC-MS\/MS approach","volume":"406","author":"Montenarh","year":"2014","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jpba.2018.06.001_bib0065","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jpba.2013.10.033","article-title":"Simultaneous determination of Olanzapine and Fluoxetine in human plasma by LC-MS\/MS: its pharmacokinetic application","volume":"90","author":"Bonde","year":"2014","journal-title":"J. Pharm. Biomed. Anal."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708518306113?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708518306113?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,3]],"date-time":"2020-11-03T01:20:16Z","timestamp":1604366416000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708518306113"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":13,"alternative-id":["S0731708518306113"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2018.06.001","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Simultaneous quantification of EVT201, a novel partial positive allosteric GABAA receptor modulator, and its two metabolites in human plasma by UHPLC\/MS\/MS","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2018.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}